PNV-DHA- ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, pyridoxine, folic acid, cyanocobalamin, calcium, ferrous fumarate, magnesium, doconexent capsule, gelatin coated

מדינה: ארצות הברית

שפה: אנגלית

מקור: NLM (National Library of Medicine)

קנה את זה

הורד מאפייני מוצר (SPC)
15-01-2024

מרכיב פעיל:

ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R), CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41), .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) (.ALPHA.-TOCOPHEROL, DL- - UNII:7QWA1RIO01), PYRIDOXINE (UNII: KV2JZ1BI6Z) (PYRIDOXINE - UNII:KV2JZ1BI6Z), FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8), CYANOCOBALAMIN (UNII: P6YC3EG204) (CYANOCOBALAMIN - UNII:P6YC3EG204), CALCIUM (UNII: SY7Q814VUP) (CALCIUM - UNII:SY7Q814VUP), FERROUS FUMARATE (UNII: R5L488RY0Q) (FERROUS CATION - UNII:GW89581OWR), MAGNESIUM (UNII: I38ZP9992A) (MAGNESIUM - UNII:I38ZP9992A), DOCONEXENT (UNII: ZAD9OKH9JC) (DOCONEXENT - UNII:ZAD9OKH9JC)

זמין מ:

Acella Pharmaceuticals, LLC

INN (שם בינלאומי):

ASCORBIC ACID

הרכב:

ASCORBIC ACID 85 [iU]

מסלול נתינה (של תרופות):

ORAL

סוג מרשם:

PRESCRIPTION DRUG

סממני תרפויטית:

DESCRIPTION: PNV-DHA is a prescription prenatal/postnatal multivitamin/mineral/essential fatty acid softgel. Each softgel is blue in color, opaque and imprinted with “BP 321” on one side. OTHER INGREDIENTS: bee’s wax, hydrogenated vegetable oil, lecithin, gelatin, glycerin, purified water, titanium dioxide, FD&C Blue #1, FD&C Red #3. INDICATIONS: PNV-DHA is a multivitamin/multimineral nutritional supplement indicated for use in the dietary management of patients with nutritional deficiencies or are in need of nutritional supplementation. CONTRAINDICATIONS: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

leaflet_short:

HOW SUPPLIED: PNV-DHA is supplied in child-resistant bottles of 30 softgels (NDC# 42192-321-30). Store at 20° - 25°C (68° - 77°F); excursions permitted to 15° - 30°C (59° - 86°F) [See USP Controlled Room Temperature.]

מצב אישור:

unapproved drug other

מאפייני מוצר

                                PNV-DHA- ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE,
DL-,
PYRIDOXINE, FOLIC ACID, CYANOCOBALAMIN, CALCIUM, FERROUS FUMARATE,
MAGNESIUM,
DOCONEXENT CAPSULE, GELATIN COATED
ACELLA PHARMACEUTICALS, LLC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this_
_labeling has not been approved by FDA. For further information about
unapproved_
_drugs, click here._
----------
PNV-DHA
RX ONLY
DESCRIPTION: PNV-DHA is a prescription prenatal/postnatal
multivitamin/mineral/essential fatty acid softgel. Each softgel is
blue in color, opaque and
imprinted with “BP 321” on one side.
*
†
SUPPLEMENT FACTS
SERVING SIZE 1
TABLET
AMOUNT PER
SERVING
% DV
%DV FOR
PREGNANT
OR LACTATING
WOMEN
Vitamin C
85 mg
142%
142%
Vitamin D
200 IU
50%
50%
Vitamin E
10 IU
33%
33%
Vitamin D
25 mg
1250%
1000%
Folate
1 mg
250%
125%
(L-methylfolate calcium 676 mcg (as Xolafin-B™
)
molar equivalent to 600 mcg of Folic Acid)
(folic acid, USP 400 mcg)
Vitamin B
12 mcg
200%
150%
Calcium
140 mg
14%
11%
Iron (ferrous
fumarate)
27 mg
150%
150%
Magnesium
45 mg
11%
10%
Docosahexaenoic
Acid (DHA)
(from omega-3 fatty
acids)
300 mg
OTHER INGREDIENTS: bee’s wax, hydrogenated vegetable oil, lecithin,
gelatin, glycerin,
purified water, titanium dioxide, FD&C Blue #1, FD&C Red #3.
INDICATIONS: PNV-DHA is a multivitamin/multimineral nutritional
supplement indicated
Percent Daily Values are based on a 2000 calorie diet
Daily Value (DV) not established
3
6
*
12
†
†
for use in the dietary management of patients with nutritional
deficiencies or are in need
of nutritional supplementation.
CONTRAINDICATIONS: This product is contraindicated in patients with a
known
hypersensitivity to any of the ingredients.
WARNING: Ingestion of more than 3 grams of omega-3 fatty acids (such
as DHA) per
day has been shown to have potential antithrombotic effects, including
an increased
bleeding time and International Normalized Ratio (INR). Administration
of omega-3 fatty
acids should be avoided in patients taking anticoagulants and in t
                                
                                קרא את המסמך השלם